Valery Feigin: Measuring stroke and transient ischaemic attack burden in New Zealand: protocol for the fifth Auckland Regional Community Stroke Study (ARCOS V)
Listen now
Description
In 2017, for the first time, stroke, became the second most common cause of both death and disability in the world.  In New Zealand (NZ) the situation is even more dire as was previously shown through a series of population-based Auckland Regional Community Stroke Studies (ARCOS) population-based studies. The number of stroke survivors have tripled over the last three decades, and there are also significant ethnic disparities in stroke, with the risk of stroke in Māori and Pacific people two to three times greater than in NZ Europeans. In 2011-2012, the age-adjusted incidence of stroke in NZ was the fourth highest in high-income countries.  Carmen Lahiff-Jenkins Managing Editor of the International journal of Stroke spoke to Professor Valery Feigin from the National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand he is also the submitting author for the article Measuring stroke and transient ischaemic attack burden in New Zealand: protocol for the fifth Auckland Regional Community Stroke Study (ARCOS V) now online in the International Journal of Stroke.    To become a member please click here   Music is Kool Kats by Kevin McCloud 
More Episodes
Idarucizumab is a monoclonal antibody fragment with high affinity for dabigatran reversing its anticoagulant effects within minutes. Patients with acute ischemic stroke on dabigatran treatment may become eligible for thrombolysis with rt-PA. In patients on dabigatran with intracerebral hemorrhage...
Published 08/25/20
Mobile stroke units, otherwise known as MSUs have recently been introduced in the care of patients suspected of having an acute stroke, leading to shortening in the time to thrombolytics, but how does the clinical effectiveness in terms of functional outcome and survival among patients treated in...
Published 08/19/20